Furthermore, the in vivo studies using SCLC xenograft and syngeneic murine models demonstrate that downregulating S100A9 significantly reduces tumor growth, accompanied by reduced expression of proliferative and angiogenic markers. The gene discussed is S100A9; the disease is small cell lung carcinoma.